Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars. The new treatment protocols are now available on all of the Syneron Sublative compatible systems, which include elōs Plus™, eTwo™ and eMatrix™.
Stretch marks are one of the most common skin disorders, impacting 95% of women during puberty or pregnancy, and can also occur in men and children. Historically difficult to treat, striae occur when the skin is stretched from rapid growth or weight gain, and causes damage to the connective tissue in the dermis.
Acne is a common condition experienced by up to 85% of adolescents and young adults and 5% of older adults. In some patients, the healing process results in permanent, disfiguring scars. Treatments ranged from chemical peels to ablative procedures with long recovery times and risky side effects. Read More